Table 1.
Univariate analysis of SNORA38 expression and clinical pathology factor.
| Factors | Number | SNORA38 expression | x 2 | P | Crude OR (95% CI) | |
|---|---|---|---|---|---|---|
| (%) | High (%) | Low (%) | ||||
| Age (years) | 2.818 | 0.093a | ||||
| ≤ 60 | 58 (75.3) | 28 (73.7) | 30 (26.3) | 0.067b | 2.897 (0.929 - 9.035) | |
| > 61 | 19 (24.7) | 5 (26.3) | 14 (73.7) | Reference | ||
| Tumor size | 6.676 | 0.010a | ||||
| ≥ 3 cm | 43 (55.8) | 24 (55.8) | 19 (44.2) | 0.011a | 3.509 (1.329 - 9.265) | |
| < 3 cm | 34 (44.2) | 9 (26.5) | 25 (73.5) | Reference | ||
| LN Metastases | 0.006a | |||||
| Negative | 53 (66.8) | 17 (32.1) | 36 (67.9) | 8.071 | Reference | |
| Positive | 24 (31.2) | 16 (66.7) | 8 (33.3) | 0.006b | 4.235 (1.518 - 11.818) | |
| ER | 5.096 | 0.024a | ||||
| Negative | 22 (28.6) | 5 (22.7) | 17 (77.3) | |||
| Positive | 55 (71.4) | 28 (50.9) | 27 (49.1) | 0.029b | 3.526 (1.141 - 10.900) | |
| PR | 1.540 | 0.215a | ||||
| Negative | 27 (35.1) | 9 (33.3) | 18 (66.7) | Reference | ||
| Positive | 50 (64.9) | 24 (48.0) | 26 (52.0) | 0.217b | 1.846 (0.697 - 4.888) | |
| Her-2 | 0.461 | 0.497a | ||||
| Negative | 48 (62.3) | 22 (45.8) | 26 (54.2) | Reference | ||
| Positive | 29 (37.7) | 11 (37.9) | 18 (62.1) | 0.498b | 0.7222 (0.282 - 1.850) | |
| Molecular typing | 6.844 | 0.077a | ||||
| Luminal A | 20 (26.0) | 12 (60.0) | 8 (40.0) | 0.035b | 6.750 (1.145 - 39.796) | |
| Luminal B | 37 (48.0) | 17 (45.9) | 20 (54.1) | 0.114b | 3.825 (0.725 - 20.177) | |
| Her-2 | 9 (11.7) | 2 (22.2) | 7 (77.8) | 0.822b | 1.286 (0.143 - 11.543) | |
| TNBC | 11 (14.3) | 2 (18.2) | 9 (81.8) | Reference | ||
| TNM staging | 0.040a | |||||
| I | 25 (32.5) | 8 (32.0) | 17 (68.0) | 6.461 | Reference | |
| II | 45 (58.4) | 19 (42.2) | 26 (57.8) | 0.401b | 1.553 (0.556 - 4.340) | |
| III | 7 (91.0) | 6 (85.7) | 1 (14.3) | 0.028b | 12.75 (1.307 - 124.3) | |
p-value a came from Pearson chi-square tests or Fisher’s Exact Test P-value b came from logistic regression analyses.